Table 1. The general characteristics of the enrolled studies.
| Author, Reference, Year | Sample size | Age (Year) (A/B/C) | Observation indicators | Follow-up (Month) |
|---|---|---|---|---|
| Newburger (17) 1991 | B:C=273:276 | 2.9±0.1/2.9±0.1 | Coronary artery lesions in the acute phase, fever disappearance time, adverse reactions | _ |
| Qin (18) 2006 | A:B=122:120 | 4.0±2.8/4.11±2.9 | Coronary artery lesions in the acute phase, fever disappearance time | 12 |
| Sato (19) 1999 | B:C=72:73 | 1.9±1.8/2.2±1.9 | Coronary artery lesions in the acute phase, fever disappearance time | _ |
| Saulsbury (20) 2002 | B:C=51:21 | 0.25-8.5/0.25-8.5 | Coronary artery lesions in the acute phase, fever disappearance time | _ |
| Chen (21) 2006 | A:B=18:22 | <5/<5 | Coronary artery lesions in the acute phase, fever disappearance time | _ |
| Deng (22) 2005 | A:C=13:10 | 0.3-6/0.3-6 | Coronary artery lesions in the acute phase | 12 |
| Fu (23) 2010 | A:B=56:134 | 0.5-5/0.5-5 | Coronary artery lesions in the acute/ subacute phase, fever disappearance time | _ |
| Guo (24) 2009 | A:C=22:24 | 3.1±0.17/3.9±0.39 | Coronary artery lesions in the acute phase, fever disappearance time, adverse reactions | _ |
| He (25) 2003 | B:C=35:30 | 0.5-7/0.5-7 | Coronary artery lesions in the acute phase, fever disappearance time | _ |
| He (26) 2004 | A:C=10:10 | 0.3-6/0.3-6 | Coronary artery lesions in the acute phase, fever disappearance time, adverse reactions | _ |
| Li (27) 2008 | A:C=33:32 | 0.17-8/0.17-8 | Coronary artery lesions in the acute phase, fever disappearance time, adverse reactions | _ |
| Li (28) 2009 | A:C=41:40 | 0.43-7/0.43-7 | Coronary artery lesions in the acute phase, adverse reactions | _ |
| Liao (29) 2007 | A:B:C=32:34:36 | 0.25-9/0.25-9 | Coronary artery lesions in the acute phase, fever disappearance time | 6,18 |
| Liu (30) 2000 | A:B:C=28:35:24 | 3.2/2.9/2.6 | Coronary artery lesions in the acute/ subacute phase, fever disappearance time | 6 |
| Liu (31) 2004 | A:C=11:15 | 0.75-7/0.75-7 | Coronary artery lesions in the acute phase, fever disappearance time, adverse reactions | _ |
| Liu (32) 2009 | A:C=30:30 | 1.5-5/1.5-5 | Coronary artery lesions in the acute phase, fever disappearance time | _ |
| Lu (33) 2003 | B:C=30:26 | 0.17-11/0.17-11 | Coronary artery lesions in the acute phase, adverse reactions | _ |
| Peng (34) 2001 | A:B=22:20 | 0.5-5/0.5-5 | Coronary artery lesions in the acute phase, fever disappearance time, adverse reactions | 12 |
| Ruan (35) 2003 | B:C=17:15 | 0.43-8/0.43-8 | Coronary artery lesions in the acute phase, fever disappearance time, adverse reactions | _ |
| Ruan (36) 2005 | A:C=34:32 | 2.9±0.4/3.0±0.5 | Coronary artery lesions in the acute phase, fever disappearance time, adverse reactions | _ |
| Ruan (37) 2006 | B:C=20:21 | 2.6±1.5/2.4±1.4 | Coronary artery lesions in the acute phase, fever disappearance time, adverse reactions | _ |
| Yan (38) 2007 | B:C=25:22 | 0.5-9/0.5-9 | Coronary artery lesions in the acute phase, fever disappearance time | 6 |
| Yang (39) 2004 | A:C=60:51 | 2.0±1.3/2.1±1.4 | Coronary artery lesions in the acute phase, fever disappearance time | 6 |
| Yao (40) 2009 | B:C=32:32 | 0.5-11/0.5-11 | Coronary artery lesions in the acute phase, fever disappearance time | 6 |
| Yuan (41) 2009 | B:C=47:43 | 0.4-12/0.4-12 | Coronary artery lesions in the acute phase | 12 |
| Yue (42) 2006 | A:B=30:26 | 0.25-6/0.25-6 | Coronary artery lesions in the acute phase | _ |
| Zhang (43) 2007 | A:B=32:27 | 0.93-8/0.93-8 | Coronary artery lesions in the acute phase, fever disappearance time, adverse reactions | _ |
| Zhang (44) 2008 | A:B:C=39:41:38 | 3.5±0.5/3.3±0.4/3.2±0.4 | Coronary artery lesions in the acute phase, fever disappearance time | 12 |
Note: A. Aspirin+immunoglobulin 1 g/(kg•d) for 1-2 days; B. Aspirin+immunoglobulin 2 g/(kg•d) for single use; C. Aspirin+immunoglobulin 400 mg/(kg•d) for 4-5 days.